Emerging Markets Earnings: GSK CEO Witty Opens Up On China
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline’s CEO Andrew Witty opens up on emerging markets and China after some sly prompting from an analyst broke down what has been a hard stone wall.